Access Program for Use of AMD3100 to Increase Peripheral Blood Stem Cells for Transplantation in Patients Who Have Failed Standard Therapy Stem Cell Mobilization
Clinical trial NCT00291811 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00291811
- Sponsor
- Genzyme, a Sanofi Company
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
- Start date
- 2003-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.